Leadership
e-Newsletter
Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

Drug discount program needs help, researchers say

The Hill, August 13, 2014
Regulators need to provide a clearer direction for the 22-year-old federal program that provides drug discounts to safety net hospitals, researchers argued in a new paper. The RAND Corp. said the so-called 340B program faces uncertainty when it comes to eligibility and transparency that pose challenges to healthcare providers and drug companies. "Policymakers need a clear, objective description of the 340B program and the challenges it faces on the road ahead," said Andrew Mulcahy, the report's lead author, in a statement. "There are increasingly divergent views on the program's purpose and the role it should play in supporting safety net providers."